Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02256 |
| Species: | Homo sapiens |
| Position : | chr6:135418600-135418700 |
| Year: | 2016 |
| Title: | Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | acute myeloid leukemia |
| PMID: | 27354268 |
| MONDO: | MONDO:0018874 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Kasumi-1 |
| CVCL ID: | CVCL_0589 |
| Experiment Type: | Functional perturbation assay; Endogenous enhancer perturbation; Disease-variant functional analysis; In vivo functional validation |
| High Throughput Method: | GWAS |
| Low Throughput Method: | CRISPR/Cas9 genome editing; RT-qPCR; CRISPR-Cas9 endogenous deletion/editing; In vivo phenotyping |
| Target gene : | MIR3662 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|